Oracle's stock falls toward record-long losing streak in wake of Cerner...

Ionis, Pfizer scrap plans for experimental cardiovascular drug

Shares of Ionis Prescription drugs Inc. IONS, +5.11% fell 7.9% in premarket buying and selling on Monday after the corporate and Pfizer Inc. PFE, +1.80% mentioned they discontinued a program testing an experimental therapy for cardiovascular threat discount and extreme hypertriglyceridemia. The businesses mentioned that though the drug, vupanorsen, met the first endpoint in a […]